Original research
par
Landis, Rachel K. et al
Date de publication
2022
Géographie
USA
Langue de la ressource
English
Texte disponible en version intégrale
Non
Open Access / OK to Reproduce
Non
Évalué par des pairs
Yes
L’objectif
Buprenorphine is an effective medication for the treatment of opioid use disorder (OUD), but the association between prior authorization policies and quality of care for individuals receiving buprenorphine treatment is not well-understood.
Constatations/points à retenir
Prior authorization policies were associated with lower likelihood of buprenorphine treatment of at least 180 days. Prior authorization policies may reduce duration of buprenorphine treatment episodes.
La conception ou méthodologie de recherche
Medicaid data
Mots clés
Policy/Regulatory
Substitution/OAT
